» Authors » Alex Liu

Alex Liu

Explore the profile of Alex Liu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 128
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Waidyaratne G, Jalil S, Liu A, Liyanarachchi S, Makary M, Rikabi A, et al.
Dig Dis Sci . 2025 Mar; PMID: 40024959
Introduction: Transjugular intrahepatic portosystemic shunt (TIPS) is an effective intervention for managing major complications of cirrhosis including refractory ascites, hydrothorax, and variceal bleed. The impact of advanced age on outcomes...
2.
Ayubcha C, Sajed S, Omara C, Veldman A, Singh S, Lokesha Y, et al.
J Imaging . 2024 Dec; 10(12). PMID: 39728216
Deep learning has shown significant value in automating radiological diagnostics but can be limited by a lack of generalizability to external datasets. Leveraging the geometric principles of non-Euclidean space, certain...
3.
Liu A, Rao W, Watt K
Liver Transpl . 2024 Dec; PMID: 39724652
Malignancy has a crucial impact on long-term survival after liver transplantation. There have been enhanced early detection rates with refined cancer screening and improved prognosis for many cancer diagnoses in...
4.
Yin Y, Holoubek J, Kim K, Liu A, Bhamwala B, Wang S, et al.
Angew Chem Int Ed Engl . 2024 Dec; 64(8):e202420411. PMID: 39648818
The concept of employing highly concentrated electrolytes has been widely incorporated into electrolyte design, due to their enhanced Li-metal passivation and oxidative stability compared to their diluted counterparts. However, issues...
5.
Holoubek J, Yu K, Wu J, Wang S, Li M, Gao H, et al.
Proc Natl Acad Sci U S A . 2023 Oct; 120(41):e2310714120. PMID: 37782794
The future application of Li metal batteries (LMBs) at scale demands electrolytes that endow improved performance under fast-charging and low-temperature operating conditions. Recent works indicate that desolvation kinetics of Li...
6.
Agarwal M, Liu A, Almquist D, Langlais B, Leventakos K, Yu N, et al.
Cancer . 2023 Aug; 129(22):3546-3553. PMID: 37548029
Background: Immune checkpoint inhibitor combined with platinum-etoposide is the standard first-line therapy for patients with extensive-stage small cell lung cancer (ES-SCLC). The phase 3 clinical trials that led to the...
7.
Liu A, Ben-Zion S, Schwartz A, Mahan J, Reed S
Patient Educ Couns . 2023 Jul; 115:107906. PMID: 37478547
Objective: Engagement in calm, compassionate care (CCC) is important in fostering patient-centered care. We aimed to study factors which predict confidence in providing CCC in pediatric residents. Methods: We performed...
8.
Agarwal M, Liu A, Langlais B, Leventakos K, Yu N, Almquist D, et al.
Clin Lung Cancer . 2023 Jun; 24(7):591-597. PMID: 37365076
Background: Studies demonstrated that chemoimmunotherapy prolongs progression-free survival (PFS) and overall survival (OS) in patients with extensive-stage small-cell lung cancer (ES-SCLC) and an Eastern Cooperative Oncology Group performance status (ECOG...
9.
Liu A, Angirekula M, Elhawary A, Mara K, Kulai T, Leise M, et al.
Clin Transplant . 2023 Jun; 37(10):e15050. PMID: 37329298
Background: Liver transplant (LT) recipients with untreated hepatitis C (HCV) are at risk for cirrhosis graft failure. The advent of direct acting antiviral agents (DAA) has improved outcomes in HCV....
10.
Du L, Ernani V, Liu A, Schild S, Jaroszewski D, Cassivi S, et al.
Oncol Lett . 2023 Feb; 25(2):80. PMID: 36742364
The objective of the present study was to characterize the difference in 10-year carcinoid-specific survival (CSS) and disease-free survival (DFS) among patients with resected pulmonary typical carcinoid (TC) and atypical...